SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001609351-18-000036
Filing Date
2018-04-20
Accepted
2018-04-20 16:39:16
Documents
5
Period of Report
2017-12-31
Effectiveness Date
2018-04-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2018proxystatementform.htm DEF 14A 971476
2 a2018proxybackpage.jpg GRAPHIC 253537
3 a2018proxyfrontpage.jpg GRAPHIC 230637
4 SPARK LOGO sparklogoa01.jpg GRAPHIC 81426
5 sparkproxy3.jpg GRAPHIC 20261
  Complete submission text file 0001609351-18-000036.txt   1774099
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36819 | Film No.: 18767191
SIC: 2836 Biological Products, (No Diagnostic Substances)